IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Penn, J. S.
Right arrow Articles by Lowery, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Penn, J. S.
Right arrow Articles by Lowery, L. A.

Investigative Ophthalmology & Visual Science, Vol 34, 576-585, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Variable oxygen exposure causes preretinal neovascularization in the newborn rat

JS Penn, BL Tolman and LA Lowery
Arkansas Center for Eye Research, University of Arkansas for Medical Sciences, Little Rock.

PURPOSE. To test the hypothesis that variable hyperoxia potentiates preretinal neovascularization in newborn rats, and to establish a more reliable animal model of ROP in which therapies designed to inhibit abnormal angiogenesis can be tested. METHODS. Immediately after birth, litters of Sprague Dawley albino rats and mothers were placed in an incubator containing 40% oxygen. After 12 hours, the oxygen was increased to 80% with a transition time of less than 1 min. For the ensuing 7, 10, or 14 days, the oxygen was altered between 40% and 80% every 12 hr in a stepwise fashion. Other litters were kept in constant 80% oxygen or in room air for the same three time periods. After exposure, rats were either killed or placed in room air for an additional 2, 4, or 7 days before being killed. RESULTS. When rats were killed immediately after oxygen exposure, the resulting vessel loss in rats exposed to 40%/80% oxygen was identical to that of animals exposed to 80% (vessels constituted 12.2 +/- 2.2% of total retinal area in cyclic oxygen vs 12.0 +/- 1.2% in constant oxygen). However, preretinal neovascularization subsequently occurred in 66% (63/96) of all rats exposed to cyclic oxygen followed by a room air period but in no rats (0/50) exposed to constant oxygen followed by room air. Preretinal vascular proliferation consisted of glomerular tufts of endothelial cells, or mature, lumenized vessels containing red blood cells. CONCLUSIONS. Consistency of oxygen therapy is more important than overall oxygen level in inducing retinopathy. Consideration should be given to tighter control of intended oxygen therapy in premature infants, regardless of the target saturation level.


This article has been cited by other articles:


Home page
 IOVSHome page
E. M. Dioum, S. L. Clarke, K. Ding, J. J. Repa, and J. A. Garcia
HIF-2{alpha}-Haploinsufficient Mice Have Blunted Retinal Neovascularization Due to Impaired Expression of a Proangiogenic Gene Battery
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2714 - 2720.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Saito, A. Uppal, G. Byfield, S. Budd, and M. E. Hartnett
Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1591 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. D. Akula, R. M. Hansen, M. E. Martinez-Perez, and A. B. Fulton
Rod Photoreceptor Function Predicts Blood Vessel Abnormality in Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4351 - 4359.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. M. Barnett, G. W. McCollum, J. A. Fowler, J. J.-W. Duan, J. D. Kay, R.-Q. Liu, D. P. Bingaman, and J. S. Penn
Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 907 - 915.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Q. Werdich and J. S. Penn
Specific Involvement of Src Family Kinase Activation in the Pathogenesis of Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5047 - 5056.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. L. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle
Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1101 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. D. Modanlou, Z. Gharraee, J. Hasan, J. Waltzman, S. Nageotte, and K. D. A. Beharry
Ontogeny of VEGF, IGF-I, and GH in Neonatal Rat Serum, Vitreous Fluid, and Retina from Birth to Weaning
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 738 - 744.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. van Wijngaarden, D. J. Coster, H. M. Brereton, I. L. Gibbins, and K. A. Williams
Strain-Dependent Differences in Oxygen-Induced Retinopathy in the Inbred Rat
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1445 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Ding, M. Scortegagna, R. Seaman, D. G. Birch, and J. A. Garcia
Retinal Disease in Mice Lacking Hypoxia-Inducible Transcription Factor-2{alpha}
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1010 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. V. Ohlmann, E. Adamek, A. Ohlmann, and E. Lutjen-Drecoll
Norrie Gene Product Is Necessary for Regression of Hyaloid Vessels
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2384 - 2390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. L. Wilkinson-Berka, S. Babic, T. de Gooyer, A. W. Stitt, K. Jaworski, L. G. T. Ong, D. J. Kelly, and R. E. Gilbert
Inhibition of Platelet-Derived Growth Factor Promotes Pericyte Loss and Angiogenesis in Ischemic Retinopathy
Am. J. Pathol., April 1, 2004; 164(4): 1263 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. A. Berkowitz, H. Luan, and R. L. Roberts
Effect of Methylimidazole-Induced Hypothyroidism in a Model of Low Retinal Neovascular Incidence
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 919 - 921.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. H. Davies, J. P. Eubanks, and M. R. Powers
Increased Retinal Neovascularization in Fas Ligand-Deficient Mice
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3202 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. G. McGuire, T. R. Jones, N. Talarico, E. Warren, and A. Das
The Urokinase/Urokinase Receptor System in Retinal Neovascularization: Inhibition by A6 Suggests a New Therapeutic Target
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2736 - 2742.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. E. Bullard, X. Qi, and J. S. Penn
Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1722 - 1731.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
O. Dembinska, L. M. Rojas, S. Chemtob, and P. Lachapelle
Evidence for a Brief Period of Enhanced Oxygen Susceptibility in the Rat Model of Oxygen-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2481 - 2490.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. K. Ozaki, K. D. Beharry, K. C. Nishihara, Y. Akmal, J. G. Ang, R. Sheikh, and H. D. Modanlou
Regulation of Retinal Vascular Endothelial Growth Factor and Receptors in Rabbits Exposed to Hyperoxia
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1546 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Gao, Y. Li, J. Fant, C. E. Crosson, S. P. Becerra, and J.-x. Ma
Difference in Ischemic Regulation of Vascular Endothelial Growth Factor and Pigment Epithelium--Derived Factor in Brown Norway and Sprague Dawley Rats Contributing to Different Susceptibilities to Retinal Neovascularization
Diabetes, April 1, 2002; 51(4): 1218 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
O. Dembinska, L. M. Rojas, D. R. Varma, S. Chemtob, and P. Lachapelle
Graded Contribution of Retinal Maturation to the Development of Oxygen-Induced Retinopathy in Rats
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1111 - 1118.
[Abstract] [Full Text]

Home page
 IOVSHome page
S. Cunningham, J. R. McColm, J. Wade, K. Sedowofia, N. McIntosh, and B. Fleck
A Novel Model of Retinopathy of Prematurity Simulating Preterm Oxygen Variability in the Rat
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4275 - 4280.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
H. Ozaki, M.-S. Seo, K. Ozaki, H. Yamada, E. Yamada, N. Okamoto, F. Hofmann, J. M. Wood, and P. A. Campochiaro
Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal Neovascularization
Am. J. Pathol., February 1, 2000; 156(2): 697 - 707.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. A. Neely and T. W. Gardner
Ocular Neovascularization : Clarifying Complex Interactions
Am. J. Pathol., September 1, 1998; 153(3): 665 - 670.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology